BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 23612017)

  • 1. Aberrant expression of CCR4 in diffuse large B-cell lymphoma, not otherwise specified.
    Nakayama S; Yokote T; Hirata Y; Iwaki K; Akioka T; Miyoshi T; Hiraoka N; Takayama A; Nishiwaki U; Masuda Y; Nishimura Y; Tsuji M; Hanafusa T
    Leukemia; 2013 Dec; 27(12):2382-5. PubMed ID: 23612017
    [No Abstract]   [Full Text] [Related]  

  • 2. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes.
    Lossos IS; Czerwinski DK; Alizadeh AA; Wechser MA; Tibshirani R; Botstein D; Levy R
    N Engl J Med; 2004 Apr; 350(18):1828-37. PubMed ID: 15115829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggressive primary testicular diffuse large B-cell lymphoma, not otherwise specified with expression of interferon-γ and its receptors.
    Nakayama-Ichiyama S; Yokote T; Hirata Y; Iwaki K; Nishiwaki U; Miyoshi T; Masuda Y; Akioka T; Tsuji M; Hanafusa T
    Acta Oncol; 2012 Jul; 51(6):814-6. PubMed ID: 22283493
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of multiple cytokines and CCR4 in primary testicular diffuse large B-cell lymphoma, not otherwise specified, involving the skin.
    Nakayama-Ichiyama S; Iwaki K; Yokote T; Tsuji M; Hirata Y; Hanafusa T
    Br J Haematol; 2012 Feb; 156(4):420. PubMed ID: 22098482
    [No Abstract]   [Full Text] [Related]  

  • 5. New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma.
    Frick M; Dörken B; Lenz G
    Best Pract Res Clin Haematol; 2012 Mar; 25(1):3-12. PubMed ID: 22409819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated profiling of diffuse large B-cell lymphoma with 7q gain.
    Chigrinova E; Mian M; Shen Y; Greiner TC; Chan WC; Vose JM; Inghirami G; Chiappella A; Baldini L; Ponzoni M; Ferreri AJ; Franceschetti S; Gaidano G; Tucci A; Facchetti F; Lazure T; Lambotte O; Montes-Moreno S; Piris MA; Zucca E; Kwee I; Bertoni F
    Br J Haematol; 2011 May; 153(4):499-503. PubMed ID: 21418177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular outcome prediction in diffuse large-B-cell lymphoma.
    Alizadeh AA; Gentles AJ; Lossos IS; Levy R
    N Engl J Med; 2009 Jun; 360(26):2794-5. PubMed ID: 19553658
    [No Abstract]   [Full Text] [Related]  

  • 8. Diffuse large B-cell lymphoma.
    Habermann TM
    Clin Adv Hematol Oncol; 2005 Nov; 3(11):suppl 4-5. PubMed ID: 16491628
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA repair in diffuse large B-cell lymphoma: a molecular portrait.
    Bret C; Klein B; Cartron G; Schved JF; Constantinou A; Pasero P; Moreaux J
    Br J Haematol; 2015 Apr; 169(2):296-9. PubMed ID: 25369781
    [No Abstract]   [Full Text] [Related]  

  • 10. Double-hit diffuse large B-cell lymphoma.
    Friedberg JW
    J Clin Oncol; 2012 Oct; 30(28):3439-43. PubMed ID: 22949152
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary mediastinal large B-cell lymphoma.
    Faris JE; LaCasce AS
    Clin Adv Hematol Oncol; 2009 Feb; 7(2):125-33. PubMed ID: 19367254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab with chemotherapy improves survival of non-germinal center type untreated diffuse large B-cell lymphoma.
    Saito B; Shiozawa E; Usui T; Nakashima H; Maeda T; Hattori N; Shimozuma J; Adachi D; Yamochi-Onizuka T; Takimoto M; Nakamaki T; Ota H; Tomoyasu S
    Leukemia; 2007 Dec; 21(12):2563-6. PubMed ID: 17597802
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of molecular subtype in predicting outcome of AIDS-related diffuse large B-cell lymphoma.
    Dunleavy K; Wilson WH
    J Clin Oncol; 2010 Jun; 28(16):e260; author reply e261-2. PubMed ID: 20421532
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction between BCL2 and interleukin-10 gene polymorphisms alter outcomes of diffuse large B-cell lymphoma following rituximab plus CHOP chemotherapy.
    Park YH; Sohn SK; Kim JG; Lee MH; Song HS; Kim MK; Jung JS; Lee JJ; Kim HJ; Kim DH
    Clin Cancer Res; 2009 Mar; 15(6):2107-15. PubMed ID: 19276283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State-of-the-art therapeutics: diffuse large B-cell lymphoma.
    Coiffier B
    J Clin Oncol; 2005 Sep; 23(26):6387-93. PubMed ID: 16155024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab regulates signaling pathways and alters gene expression associated with cell death and survival in diffuse large B-cell lymphoma.
    Koivula S; Valo E; Raunio A; Hautaniemi S; Leppä S
    Oncol Rep; 2011 Apr; 25(4):1183-90. PubMed ID: 21318224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
    Coiffier B; Lepage E; Briere J; Herbrecht R; Tilly H; Bouabdallah R; Morel P; Van Den Neste E; Salles G; Gaulard P; Reyes F; Lederlin P; Gisselbrecht C
    N Engl J Med; 2002 Jan; 346(4):235-42. PubMed ID: 11807147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse large B-cell lymphoma, not otherwise specified, associated with coinfection of human herpesvirus 6 and 8.
    Nakayama-Ichiyama S; Yokote T; Oka S; Iwaki K; Kobayashi K; Hirata Y; Hiraoka N; Takayama A; Akioka T; Miyoshi T; Takubo T; Tsuji M; Hanafusa T
    J Clin Oncol; 2011 Jul; 29(21):e636-7. PubMed ID: 21606415
    [No Abstract]   [Full Text] [Related]  

  • 19. Microenvironmental protection in diffuse large-B-cell lymphoma.
    Eng C
    N Engl J Med; 2008 Nov; 359(22):2379-81. PubMed ID: 19038884
    [No Abstract]   [Full Text] [Related]  

  • 20. Diffuse large B cell lymphoma: how can we cure more patients in 2012?
    Moskowitz C
    Best Pract Res Clin Haematol; 2012 Mar; 25(1):41-7. PubMed ID: 22409822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.